The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg …
G Csemiczky, T Dieben, HJC Bennink, BM Landgren - Contraception, 1996 - Elsevier
During oral treatment with 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21
days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …
days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …
The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg …
G Csemiczky, T Dieben, CB HJ, BM Landgren - Contraception, 1996 - europepmc.org
During oral treatment with 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for
21 days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …
21 days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …
[引用][C] The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg …
G CSEMICZKY, T DIEBEN… - Contraception …, 1996 - pascal-francis.inist.fr
The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17β-estradiol
and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days …
and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days …
The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg …
G Csemiczky, T Dieben, HJC Bennink… - …, 1996 - pubmed.ncbi.nlm.nih.gov
During oral treatment with 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for
21 days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …
21 days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …
The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg …
G Csemiczky, T Dieben, HJC Bennink… - …, 1996 - contraceptionjournal.org
During oral treatment with 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21
days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …
days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …
The Pharmacodynamic Effects of an Oral Contraceptive Containing 3 mg Micronized 17β-Estradiol and 0.150 mg Desogestrel for 21 Days, Followed by 0.030 mg …
G Csemiczky, T Dieben, HJC Bennink, BM Landgren - Contraception, 1996 - infona.pl
During oral treatment with 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21
days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …
days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …